These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2217484)

  • 1. Oncogene expression in prostate cancer.
    Schalken JA; Bussemakers MJ; Debruyne FM
    Prog Clin Biol Res; 1990; 357():97-105. PubMed ID: 2217484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors and oncogenes in prostate cancer.
    Thompson TC
    Cancer Cells; 1990 Nov; 2(11):345-54. PubMed ID: 2282250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new prostate cancer progression markers by differential hybridization analysis.
    Schalken JA; Debruyne FM
    Eur Urol; 1992; 21 Suppl 1():60-5. PubMed ID: 1425840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer.
    Turner DP; Watson DK
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):33-42. PubMed ID: 18095881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal and molecular biological factors in pathogenesis of prostate cancer].
    Zezerov EG
    Vopr Onkol; 2001; 47(2):174-81. PubMed ID: 11383453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers associated with prostate cancer progression.
    Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
    J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular pathology of urological malignancies.
    Dorkin TJ; Robson CN; Neal DE
    J Pathol; 1997 Dec; 183(4):380-7. PubMed ID: 9496253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncogenes and the malignancy process].
    Mares J; Sedlácek Z; Goetz P
    Cas Lek Cesk; 1996 May; 135(11):335-9. PubMed ID: 8706068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of prostate-cancer pathogenesis.
    Shand RL; Gelmann EP
    Curr Opin Urol; 2006 May; 16(3):123-31. PubMed ID: 16679847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in oncogene and antioncogene research].
    Toyoshima K; Akiyama T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):751-6. PubMed ID: 1351383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular prognostic markers for urogenital cancers].
    Kubota Y
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):997-1003. PubMed ID: 8687235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biologic aspects of human prostatic carcinoma.
    Netto GJ; Humphrey PA
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in oncogene studies].
    Toyoshima K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2135-9. PubMed ID: 3606142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances on molecular pathology of prostate carcinoma].
    Niu HL; Tao Y
    Ai Zheng; 2003 May; 22(5):552-6. PubMed ID: 12753724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.